Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,332,629 papers from all fields of science
Search
Sign In
Create Free Account
haloperidol decanoate
Known as:
haloperidol decanoate [Chemical/Ingredient]
The decanoate ester of haloperidol, a phenylbutylpiperadine derivative with antipsychotic, neuroleptic and antiemetic effects. Haloperidol…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
1 ML haloperidol decanoate 100 MG/ML Injection
1 ML haloperidol decanoate 50 MG/ML Injection [Haldol]
Bone Marrow Diseases
Child Behavior Disorders
Expand
Broader (2)
Antipsychotic Agents
Haloperidol
Narrower (1)
Haldol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Depot haloperidol decanoate for schizophrenia (Review)
Quraishi Sn
,
A. David
,
M. Brasil
,
F. V. Alheira
2009
Corpus ID: 74581700
Background The mainstay of treatment for schizophrenia is the antipsychotic group of drugs. These are usually given orally but…
Expand
Review
1999
Review
1999
Review: haloperidol decanoate is superior to placebo for schizophrenia
S. Thelander
1999
Corpus ID: 56695127
Main results 11 studies met inclusion criteria. 2 studies (88 patients) compared haloperidol decanoate with placebo. A…
Expand
1996
1996
[Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].
A. Viala
,
N. Aymard
,
A. Leyris
,
F. Caroli
The´rapie (Paris)
1996
Corpus ID: 26528186
The study concerned 7 patients suffering from schizophrenic disorder according to the DSM III R criteria, treated with a stable…
Expand
1991
1991
Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate.
Youssef Ha
1991
Corpus ID: 78024282
The role of neuroleptic drugs in controlling acute psychotic symptoms and reducing relapse is well established. It is the…
Expand
1990
1990
Neurophysiologic changes during the treatment of endogenous depression by reflexotherapy
Dudaeva Ki
,
Mikhaĭlova Es
,
Poliakov Se
1990
Corpus ID: 222237019
: Superficial EEG and visual evoked potentials (EP) were studied in 28 patients with endogenous depression treated with…
Expand
1989
1989
Optimum therapeutic dosing with haloperidol decanoate
W. Meyerowitz
,
J. D. Jaramillo
,
D. Denson
,
H. Dekirmijian
1989
Corpus ID: 77828803
Haloperidol decanoate was recently introduced in the United States. To determine whether there is a correlation between the…
Expand
1987
1987
[Clinical pharmacokinetics of haloperidol decanoate. Comparison with other prolonged-action neuroleptics].
J. Levron
,
R. Ropert
L'Encephale
1987
Corpus ID: 25386375
Precise pharmacokinetic data of long-acting neuroleptics: apparent half life (T 1/2), time of peak plasma concentration (Tmax…
Expand
1986
1986
Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
J. Cookson
,
N. M. Kennedy
,
D. Gribbon
International Clinical Psychopharmacology
1986
Corpus ID: 42474121
A one year double-blind trial of haloperidol decanoate and fluphenazine decanoate was conducted in nineteen out-patients who had…
Expand
1986
1986
The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate.
Leff Jp
,
Tress Kh
1986
Corpus ID: 148020780
: A group of 13 untreated schizophrenic patients was collected over two and a half years. They were prescribed a standard regime…
Expand
1983
1983
Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
G. Meco
,
Massimo Casacchia
,
M. Attenni
,
A. Iafrate
,
F. Castellana
,
U. Ecari
Acta psychiatrica Belgica
1983
Corpus ID: 1319792
The recently synthesized depot neuroleptic haloperidol decanoate (HD) has been mainly used in the treatment of chronic…
Expand